InvestorsHub Logo
Followers 41
Posts 5414
Boards Moderated 0
Alias Born 11/15/2013

Re: None

Saturday, 06/21/2014 11:54:22 PM

Saturday, June 21, 2014 11:54:22 PM

Post# of 403046
Kevetrin displayed a broad spectrum anticancer activity in xenograft
tumor models (lung, breast, colon, prostate, squamous cell,
and leukemia),while being well tolerated with low toxicity.

IMO. Since oustanding results and low toxicity was demonstrated in human xenograft mouse studies, Dr Frei with DF knew Cellceutix had a winner with Kevetrin for testing on late stage multi drug resistant cancer patients.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News